Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Post by hmmmmmmmmon Oct 03, 2022 11:35am
263 Views
Post# 35001619

Operating Capital?

Operating Capital?Are we down to our last week or two of operating capital? 

Spoectral believes it can operate like this without a word to shareholders?

Each of us need to take 1 minute and send a polite/ clear email asking for a statement.

Below are the company and board emails that are available online.

cseto@spectraldx.com
 
pwalker@spectraldx.com
 
bmcinnis@spectraldx.com
 
jkellum@spectraldx.com
 
edt@crescendo-ir.com

Anthony.Bihl@bioventusglobal.com

john.nosenzo@bioventusglobal.com


<< Previous
Bullboard Posts
Next >>